Fennec Pharmaceuticals Inc. logo

Fennec Pharmaceuticals Inc.

NASDAQ:FENC

Overview | Financials
Company Name Fennec Pharmaceuticals Inc.
Symbol FENC
Currency USD
Price 4.36
Market Cap 119,288,292
Dividend Yield 0%
52-week-range 4.09 - 11.92
Industry Biotechnology
Sector Healthcare
CEO Mr. Rostislav Raykov
Website https://www.fennecpharma.com

An error occurred while fetching data.

About Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals

Related Stocks

Clene Inc. logo

Clene Inc.

CLNN

5.89 USD

Savara Inc. logo

Savara Inc.

SVRA

4.02 USD

High Tide Inc. logo

High Tide Inc.

HITI

2.72 USD

Compugen Ltd. logo

Compugen Ltd.

CGEN

1.81 USD

NeuroPace, Inc. logo

NeuroPace, Inc.

NPCE

7.56 USD

Quipt Home Medical Corp. logo

Quipt Home Medical Corp.

QIPT

2.72 USD

Vor Biopharma Inc. logo

Vor Biopharma Inc.

VOR

0.834 USD

Harvard Bioscience, Inc. logo

Harvard Bioscience, Inc.

HBIO

2.39 USD

Financials

Numbers are in millions USD

Numbers are in millions USD